Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
135 |
|
Actual shortage: | 33 (24%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 102 (76%) | |
Discontinuation Reports |
29 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 29 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (45%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-TOPIRAMATE | 200MG | TABLET | Actual shortage | 2024-01-29 | 2024-01-29 | 217687 |
MINT-ATORVASTATIN | 10MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217690 |
MINT-ATORVASTATIN | 20MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217693 |
MINT-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-01-29 | 2024-01-30 | 217696 |
MINT-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-19 | 2024-03-19 | 222750 |
MINT-PRAVASTATIN | 20MG | TABLET TABLET | Actual shortage | 2024-01-26 | 2024-03-25 | 217378 |
MINT-TOPIRAMATE | 25MG | TABLET | Resolved | 2024-01-29 | 2024-03-26 | 217681 |
MINT-PRAVASTATIN | 10MG | TABLET TABLET | Resolved | 2024-01-26 | 2024-03-26 | 217375 |
MINT-PRAVASTATIN | 40MG | TABLET TABLET | Resolved | 2024-01-26 | 2024-03-26 | 217381 |
MINT-ANASTROZOLE | 1MG | TABLET | Resolved | 2024-01-26 | 2024-03-26 | 217369 |
MINT-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-03-26 | 217390 |
MINT-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-03-26 | 217393 |
MINT-BETAHISTINE | 8MG | TABLET | Actual shortage | 2024-06-10 | 2024-06-10 | 230038 |
MINT-BETAHISTINE | 16MG | TABLET | Actual shortage | 2024-06-10 | 2024-06-10 | 230041 |
MINT-BETAHISTINE | 24MG | TABLET | Actual shortage | 2024-06-10 | 2024-06-10 | 230044 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-FENOFIBRATE E | 145MG | TABLET | Discontinued | 2020-04-25 | 2020-04-25 | 113175 |
MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
MINT-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170853 |
MINT-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170856 |
MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
MINT-CITALOPRAM | 20MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191439 |
MINT-CITALOPRAM | 40MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191442 |